Author： Bielecka-Dabrowa Agata Rysz Jacek Mikhailidis Dimitri P Banach Maciej
Publisher： Informa Healthcare
ISSN： 1465-6566
Source： Expert Opinion on Pharmacotherapy, Vol.12, Iss.15, 2011-10, pp. : 2329-2338
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Cruz Constança S Cruz Luzia S Domingues Gustavo S Marcílio de Souza Carlos A
Expert Opinion on Drug Safety, Vol. 4, Iss. 4, 2005-07 ,pp. :
Access to resources
Recommend
Thiazolidinediones increase risk of heart failure
Inpharma, Vol. 1, Iss. 1418, 2003-01 ,pp. :
How serious is heart failure risk with pioglitazone?
Reactions Weekly, Vol. 1, Iss. 1182, 2007-01 ,pp. :
Valsartan reduces risk of atrial fibrillation in heart failure
Inpharma, Vol. 1, Iss. 1488, 2005-01 ,pp. :
Thiazolidinediones may increase risk of heart failure
Inpharma, Vol. 1, Iss. 1599, 2007-01 ,pp. :